Literature DB >> 21492177

Nigella sativa seed extract and its bioactive compound thymoquinone: the new melanogens causing hyperpigmentation in the wall lizard melanophores.

Sharique A Ali1, Keisham V Meitei.   

Abstract

OBJECTIVE: The effects of the lyophilized seed extract of Nigella sativa and its active ingredient, thymoquinone, were studied on the isolated melanophores of the wall lizard to find the mechanism of skin darkening at the cellular level.
METHODS: The integumental melanophores of the wall lizard, Hemidactylus flaviviridis, were assayed using the mean melanophore size index and their responses were recorded in the presence of various concentrations of the plant extract, thymoquinone, specific antagonists and potentiator. KEY
FINDINGS: Significant skin darkening activity of the extract of N. sativa and thymoquinone was observed on the isolated melanophores of the wall lizard. The pigment cells responded by distinct dispersion leading to skin darkening. The effect was physiologically significant as re-immersion in physiological saline made the melanophores return to their normal intermediate state. These melanin dispersal effects were antagonized by atropine as well as hyoscine and were also found to be highly potentiated by neostigmine, an anticholinesterase agent.
CONCLUSIONS: These findings suggest that the extract of N. sativa, as well as its active principle, mimic the action of acetylcholine in melanin dispersion leading to skin darkening via stimulation of cholinergic receptors of muscarinic nature within the melanophores of wall lizard. This study opens new vistas for the use of N. sativa active ingredient, thymoquinone, as a novel melanogen for its clinical application in skin disorders such as hypopigmentation or vitiligo.
© 2011 The Authors. JPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21492177     DOI: 10.1111/j.2042-7158.2011.01271.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

1.  Comparing Nigella sativa Oil and Fish Oil in Treatment of Vitiligo.

Authors:  Alireza Ghorbanibirgani; Ali Khalili; Darioush Rokhafrooz
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

Review 2.  A Review on the Cosmeceutical and External Applications of Nigella sativa.

Authors:  Ahmad M Eid; Nagib A Elmarzugi; Laila M Abu Ayyash; Maher N Sawafta; Hadeel I Daana
Journal:  J Trop Med       Date:  2017-11-22

Review 3.  Links between the Prophet Muhammad (PBUH) recommended foods and disease management: A review in the light of modern superfoods.

Authors:  Sharique A Ali; Naima Parveen; Ayesha S Ali
Journal:  Int J Health Sci (Qassim)       Date:  2018 Mar-Apr

4.  Understanding the ultrastructural aspects of berberine-induced skin-darkening activity in the toad, Bufo melanostictus, melanophores.

Authors:  Sharique A Ali; Ishrat Naaz
Journal:  J Microsc Ultrastruct       Date:  2015-08-05

5.  Thymocid®, a Standardized Black Cumin (Nigella sativa) Seed Extract, Modulates Collagen Cross-Linking, Collagenase and Elastase Activities, and Melanogenesis in Murine B16F10 Melanoma Cells.

Authors:  Huifang Li; Nicholas A DaSilva; Weixi Liu; Jialin Xu; George W Dombi; Joel A Dain; Dongli Li; Jean Christopher Chamcheu; Navindra P Seeram; Hang Ma
Journal:  Nutrients       Date:  2020-07-19       Impact factor: 5.717

6.  The effect of nigella sativa oil on the prevention of phlebitis induced by chemotherapy: a clinical trial.

Authors:  Niaz Behnamfar; Zohreh Parsa Yekta; Faraz Mojab; Seyyed Mohammad Kazem Naeini
Journal:  Biomedicine (Taipei)       Date:  2019-08-27

7.  Quantifying pigment cover to assess variation in animal colouration.

Authors:  Andjin Siegenthaler; Debapriya Mondal; Chiara Benvenuto
Journal:  Biol Methods Protoc       Date:  2017-03-27

8.  Potential Antidepressant Constituents of Nigella sativa Seeds.

Authors:  Ehab S Elkhayat; Mohammad S Alorainy; Ibrahim M El-Ashmawy; Shawkat Fat'hi
Journal:  Pharmacogn Mag       Date:  2016-01       Impact factor: 1.085

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.